Hyperuricaemia in the general practitioner‘s office

Artur Mamcarz; Marcin Wełnicki; Agnieszka Mastalerz-Migas

eISSN: 2450-4459
ISSN: 2450-3517

Lekarz POZ

Current issue Archive Manuscripts accepted About the journal Supplements Abstracting and indexing Subscription Contact Instructions for authors

Editorial System

Submit your Manuscript

2/2019
vol. 5

Send email

Copy url:

abstract:

Review paper

Hyperuricaemia in the general practitioner‘s office

Artur Mamcarz

¹

,

Marcin Wełnicki

¹

,

Agnieszka Mastalerz-Migas

²

III Klinika Chorób Wewnętrznych i Kardiologii Warszawskiego Uniwersytetu Medycznego, Międzyleski Szpital Specjalistyczny w Warszawie
Katedra i Zakład Medycyny Rodzinnej, Uniwersytet Medyczny we Wrocławiu

Online publish date: 2019/07/09

View full text Get citation

Asymptomatic hyperuricaemia has become a topic of interest for cardiologists in recent years. Uric acid, previously identified mainly with gout and some oncological diseases, has proven to be an independent risk factor for cardiovascular disease. A number of studies indicate that asymptomatic hyperuricaemia is also an independent risk factor for cardiovascular death. Experts now agree that the determination of uric acid should be routine laboratory testing in the majority of our patients. The existing norms for uric acid concentration also need to be verified. In patients with concomitant hypertension, diabetes, dyslipidaemia, or chronic kidney disease a level of uric acid exceeding5 mg/dl should be considered abnormal.

keywords:

Hyperuricaemia in the general practitioner‘s office

Artur Mamcarz 1 , Marcin Wełnicki 1 , Agnieszka Mastalerz-Migas 2

allopurinol, uric acid, cardiovascular risk

Artur Mamcarz

¹

,

Marcin Wełnicki

¹

,

Agnieszka Mastalerz-Migas

²